HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-alpha Reductase inhibitors in prostate cancer: from clinical trials to clinical practice.

AuthorsBehfar Ehdaie, Karim A Touijer
JournalEuropean urology (Eur Urol) Vol. 63 Issue 5 Pg. 788-9; discussion 790-1 (May 2013) ISSN: 1873-7560 [Electronic] Switzerland
PMID23305882 (Publication Type: Editorial, Comment)
Chemical References
  • 5-alpha Reductase Inhibitors
  • Antineoplastic Agents, Hormonal
  • Azasteroids
  • KLK3 protein, human
  • Kallikreins
  • Prostate-Specific Antigen
  • Dutasteride
Topics
  • 5-alpha Reductase Inhibitors (administration & dosage)
  • Antineoplastic Agents, Hormonal (administration & dosage)
  • Azasteroids (administration & dosage)
  • Dutasteride
  • Humans
  • Kallikreins (blood)
  • Male
  • Prostate-Specific Antigen (blood)
  • Prostatectomy
  • Prostatic Neoplasms (drug therapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: